ZEMZEM H. TURA

A versatile and professional individual with a proven track record of successful collaboration and independent work towards achieving collective goals. Demonstrates effective multitasking and management of multiple responsibilities. Proficient in Microsoft Office Suite (Word, Excel, PowerPoint) and fluent in English (IELTS Band Score: 8). Additionally, proficient in Afan Oromo and Amharic languages. A student-centered professor with expertise in the subject matter, offering a 10-year background supporting students, developing instructional plans, and organizing and grading exams and tests. Commended for sustaining an effective learning environment through prepared classes and relevant assignments, consistently achieving classroom management and academic goals. An inspiring professor who brings advanced teaching skills and department leadership experience. Goal-oriented to advance the department, improve teaching, and modernize courses. Possesses an extensive background in research.

• ABERTAY OVERSEAS MERIT SCHOLARSHIP, 2011
• Participated in cultural shows of food, clothing and dance representing Ethiopia on international students’ day.
• As a member of Science club participated in conducting competition on posture presentation, model preparations and quiz competitions.

• Dr Yusuf Deeni, Lecturer (Asst Professor) Biotechnology & Biological Sciences, University of Abertay Dundee, United Kingdom, y.deeni@abertay.ac.uk
• Dr. Mark K Saville, Lecturer, Division of Cancer Research, Medical Research Institute, Clinical Research Centre, Dundee, Scotland, DD1 9SY, U.K., m.k.saville@dundee.ac.uk
• Dr Nia A. White CBiol MSB, Head of School of Contemporary Sciences, University of Abertay Dundee, Dundee, Scotland, DD1 1HG, U.K., N.A.White@Abertay.ac.uk

TARGETING THE PROTEASOME FOR CUTANEOUS SQUAMOUS CELL CARCINOMA THERAPY, Skin malignancies are the most common human cancer conceivably as it is the largest organ in the body which serve as a barrier, and thus exposed to carcinogens more frequently. Skin cancer is broadly categorized into melanoma and non-melanoma skin cancer (NMSC). Cutaneous squamous cell carcinoma (cSCC) is the second most common NMSC, the first being basal cell carcinoma (BCC). However, majority of NMSC death is due to cSCCs which accounts for 20% of all skin cancer related deaths (Tufaro, et al. 2011). Even though, mortality from skin cancer is relatively low, the high incidence and the potential serious skin damage presents a significant health burden (Gloster and Brodland 1996). Furthermore, 8% of cSCCs patients present with relapse, of which 5% develop an aggressive invasive tumor. In such cases a complete remission is very rare with only 10-20% survival rate over a period of 10 years. Thus there is a necessity of exploring improved treatment and prevention option., Project thesis, 60%, Grade A, Laboratory work, 30%, Grade B+, Seminar presentation, Dr. Mark Saville, Division of Cancer Research, Medical Research Institute, Dundee, Scotland, U.K.